tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Vamil Divan, 322 are a BUY (68.66%), 134 are a HOLD (28.57%), 13 are a SELL (2.77%).
Analyst Vamil Divan, currently employed at GUGGENHEIM, carries an average stock price target met ratio of 60.89% that have a potential upside of 49.59% achieved within 354 days.
Vamil Divan’s has documented 920 price targets and ratings displayed on 55 stocks. The coverage is on Healthcare, Financial Services, Technology sectors.
Most recent stock forecast was given on JNJ, Johnson & Johnson at 17-Jul-2026.
Analyst best performing recommendations are on ARAV (ARAVIVE).
The best stock recommendation documented was for KRTX (KARUNA THERAPEUTICS) at 8/9/2022. The price target of $276 was fulfilled within 3 days with a profit of $47.55 (20.81%) receiving and performance score of 69.38.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 18-Nov-2020
$282
$22.64 (8.73%)
$273
9 days ago
(22-Jul-2026)
14/17 (82.35%)
$28.7 (11.33%)
409
Hold Since 15-Jul-2026
$260
$0.64 (0.25%)
$276
16 days ago
(15-Jul-2026)
19/21 (90.48%)
$15.89 (6.51%)
284
Hold Since 07-Jan-2026
$260
$0.64 (0.25%)
$230
18 days ago
(13-Jul-2026)
2/3 (66.67%)
$12 (4.84%)
89
Buy Since 05-Feb-2024
$300
$40.64 (15.67%)
$258
18 days ago
(13-Jul-2026)
16/17 (94.12%)
$52 (20.97%)
318
Buy Since 25-Feb-2026
$280
$20.64 (7.96%)
$260
21 days ago
(10-Jul-2026)
6/7 (85.71%)
$31.92 (12.87%)
161
Which stock is Vamil Divan is most bullish on?
Which stock is Vamil Divan is most reserved on?
What Year was the first public recommendation made by Vamil Divan?
